Netflix Goes 7-For-1; Vanda Pharma And FibroGen Lead Tuesday's After-Hours Movers

Vanda Pharmaceuticals Inc. VNDA gained more than 8 percent in after-hours trading Tuesday to $13.96 after the company posted positive results from a schizophrenia relapse prevention study of its Fanapt drug. The company will seek to include the results in the drug's labeling.

Xunlei Ltd XNET rose about 5 percent in late trading to $14.79 on no obvious catalyst for the Chinese Internet platform provider.

Netflix, Inc. NFLX gained 2.7 percent to $699.77 in post-market trading after the company announced a 7-for-1 stock split.

FibroGen Inc FGEN rose 2 percent in the extended session to $23.54. The biopharma company's shares are up more than 22 percent during the past five trading days.

SAP SE SAP picked up nearly 2 percent following the bell to $75.92. SAP shares closed Tuesday little changed and the company didn't issue post-market news.

Tokai Pharmaceuticals Inc TKAI lost more than 6 percent in late trading, changing hands at $13 a share. The Boston-based biotech company is slated to present at an investor conference Wednesday.

Sohu.com Inc SOHU fell 6 percent to $61.06 in after-hours trading. The China-based online media and mobile service company didn't issue news.

Akebia Therapeutics Inc AKBA declined nearly 6 percent to $9.12 in the late session. The Cambridge, Massachusetts biopharmaceutical company had been scheduled for a presentation at a securities conference earlier Tuesday afternoon.

InterXion Holding NV INXN fell nearly 4 percent in the extended market to $28.12. The European data center services provider didn't issue news.

Esperion Therapeutics Inc ESPR declined 3.5 percent to $78.13. The Ann Arbor, Michigan drug company was slated to offer a presentation at a securities conference after the bell.